Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2013 -





Published: November 2013 | Pages: 85 | Format: PDF

 Summary 

 GlobalData's clinical trial report, "Left Ventricular Dysfunction Global Clinical Trials Review, H2, 2013" provides data on the Left Ventricular Dysfunction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Left Ventricular Dysfunction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Left Ventricular Dysfunction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. 

 Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. 

 Scope 

 - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations  

 - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type 

 - Listings of discontinued trials (suspended, withdrawn and terminated) 

 Reasons to buy 

 - Understand the dynamics of a particular indication in a condensed manner 

 - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more 

 - Obtain discontinued trial listing for trials across the globe 

 - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies 

 Table of Contents 

 Table of Contents 2 

 List of Tables 4 

 List of Figures 5 

 Introduction 6 

 Left Ventricular Dysfunction 6 

 Report Guidance 6 

 Clinical Trials by Region 7 

 Clinical Trials by Country 8 

 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 

 Top Five Countries Contributing to Clinical Trials in Europe 11 

 Top Countries Contributing to Clinical Trials in North America 12 

 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 

 Top Five Countries Contributing to Clinical Trials in Central and South America 14 

 Clinical Trials by BRIC Nations 15 

 Clinical Trials by G7 Nations 16 

 Clinical Trials in G7 Nations by Trial Status 17 

 Clinical Trials by E7 Nations 18 

 Clinical Trials in E7 Nations by Trial Status 19 

 Clinical Trials by Phase 20 

 In Progress Trials by Phase 21 

 Clinical Trials by Trial Status 22 

 Unaccomplished Trials of Left Ventricular Dysfunction 23 

 Subjects Recruited Over a Period of Time 26 

 Prominent Sponsors 27 

 Top Companies Participating in Left Ventricular Dysfunction Therapeutics Clinical Trials 29 

 Prominent Drug Comparison 31 

 Clinical Trial Profiles 32 

 Clinical Trial Overview of Top Companies 32 

 Bayer AG 32 

 Clinical Trial Overview of Bayer AG 32 

 Pfizer Inc. 33 

 Clinical Trial Overview of Pfizer Inc. 33 

 AstraZeneca PLC 34 

 Clinical Trial Overview of AstraZeneca PLC 34 

 St. Jude Medical, Inc. 35 

 Clinical Trial Overview of St. Jude Medical, Inc. 35 

 Medtronic, Inc. 36 

 Clinical Trial Overview of Medtronic, Inc. 36 

 ARCA biopharma, Inc. 37 

 Clinical Trial Overview of ARCA biopharma, Inc. 37 

 Amgen Inc. 38 

 Clinical Trial Overview of Amgen Inc. 38 

 Astellas Pharma Inc. 39 

 Clinical Trial Overview of Astellas Pharma Inc. 39 

 Actavis Group hf. 40 

 Clinical Trial Overview of Actavis Group hf. 40 

 Clinical Trial Overview of Top Institutes / Government 41 

 University Health Network 41 

 Clinical Trial Overview of University Health Network 41 

 National Heart, Lung, and Blood Institute 42 

 Clinical Trial Overview of National Heart, Lung, and Blood Institute 42 

 University of Ottawa Heart Institute 43 

 Clinical Trial Overview of University of Ottawa Heart Institute 43 

 RWTH Aachen University 44 

 Clinical Trial Overview of RWTH Aachen University 44 

 University of Miami 45 

 Clinical Trial Overview of University of Miami 45 

 University of Alabama at Birmingham 46 

 Clinical Trial Overview of University of Alabama at Birmingham 46 

 Kyoto University 47 

 Clinical Trial Overview of Kyoto University 47 

 University of Sao Paulo 48 

 Clinical Trial Overview of University of Sao Paulo 48 

 National Institutes of Health Clinical Center 49 

 Clinical Trial Overview of National Institutes of Health Clinical Center 49 

 ASKLEPIOS proresearch Klinische Forschung und Entwicklung 50 

 Clinical Trial Overview of ASKLEPIOS proresearch Klinische Forschung und Entwicklung 50 

 Five Key Clinical Profiles 51 

 Appendix 82 

 Abbreviations 82 

 Definitions 82 

 Research Methodology 83 

 Secondary Research 83 

 About GlobalData 84 

 Contact Us 84 

 Disclaimer 84 

 Source 85 

  

 List of Tables 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, North America, Top Countries, 2013* 12 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 13 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, BRIC Countries, 2013* 15 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, G7 Countries, 2013* 16 

 Left Ventricular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, E7 Countries, 2013* 18 

 Left Ventricular Dysfunction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22 

 Left Ventricular Dysfunction Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23 

 Left Ventricular Dysfunction Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 24 

 Left Ventricular Dysfunction Therapeutics Market, Global, Terminated Clinical Trials, 2013* 25 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 32 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 33 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 34 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Medical, Inc., 2013* 35 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2013* 36 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCA biopharma, Inc., 2013* 37 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2013* 38 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2013* 39 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis Group hf., 2013* 40 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2013* 41 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2013* 42 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Ottawa Heart Institute, 2013* 43 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by RWTH Aachen University, 2013* 44 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2013* 45 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013* 46 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 47 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2013* 48 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2013* 49 

 Left Ventricular Dysfunction Therapeutics Clinical Trials Market, Global, Clinical Trials by ASKLEPIOS proresearch Klinische Forschung und Entwicklung, 2013* 50 

  

 List of Figures 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 13 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, G7 Countries (%), 2013* 16 

 Left Ventricular Dysfunction Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, E7 Countries (%), 2013* 18 

 Left Ventricular Dysfunction Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21 

 Left Ventricular Dysfunction Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29 

 Left Ventricular Dysfunction Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31 

 GlobalData Methodology 83